Browse
Submit Data
Databases
API
Help

Dataset Information

19 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cyclo-Tris[?-5-(2-pyrid-yl)pyrazol-1-ido-?N,N:N]tris-ilver(I).

ABSTRACT: In the title compound, [Ag(3)(C(8)H(6)N(3))(3)], the asymmetric unit contains three silver cations and three depronated 5-(2-pyrid-yl)pyrazol-1-ide ligands. Each silver cation is chelated by one 5-(2-pyrid-yl)pyrazol-1-ide ligand, which also acts as a bridging ligand towards the next silver ion via the second pyrazole N atom. In summary, three silver cations and three deprotonated 3-(2-pyrid-yl)-1H-pyrazole ligands produce a macrocyclic trimeric coordination oligomer that exhibits an almost planar conformation (mean deviation 0.1483?Å). In addition, short non-bonding Ag?Ag inter-actions [3.127?(2)?Å] are observed.

SUBMITTER: An Z

PROVIDER: S-EPMC2971284 | biostudies-literature | 2009 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

cyclo-Tris[μ-5-(2-pyrid-yl)pyrazol-1-ido-κN,N:N]tris-ilver(I).

An Zhe Z Zhou Ru-Jin RJ

Acta crystallographica. Section E, Structure reports online 20091010 Pt 11

In the title compound, [Ag(3)(C(8)H(6)N(3))(3)], the asymmetric unit contains three silver cations and three depronated 5-(2-pyrid-yl)pyrazol-1-ide ligands. Each silver cation is chelated by one 5-(2-pyrid-yl)pyrazol-1-ide ligand, which also acts as a bridging ligand towards the next silver ion via the second pyrazole N atom. In summary, three silver cations and three deprotonated 3-(2-pyrid-yl)-1H-pyrazole ligands produce a macrocyclic trimeric coordination oligomer that exhibits an almost plan ...[more]

PMID: 21578092

Similar Datasets

Poly[aqua-bis-[?(3)-4-(3-pyrid-yl)pyrimidine-2-sulfonato-?N:N,O:O][?(2)-4-(3-pyrid-yl)pyrimidine-2-sulfonato-?N:N,O]tris-ilver(I)].

Project description:In the crystal structure of the title compound, [Ag(3)(C(9)H(6)N(3)O(3)S)(3)(H(2)O)(2)](n), the mol-ecules are linked into three-decked polymeric zigzag chains propagating in [100]. On the middle deck, the Ag atom is five-coordinated by three O atoms from three 4-(3-pyrid-yl)pyrimidine-2-sulfonate (L) ligands, one of which lies on a mirror plane with the sulfonate group disordered over two orientations in a 1:1 ratio, and two N atoms from two L ligands, which lie on the same mirror plane. On the upper and lower decks, the Ag atom is four-coordinated by an aqua ligand, one O and two N atoms from two L ligands with the pyridyl and pyrimidine rings twisted at 19.8?(2)°. In the polymeric chain, there are ?-? inter-actions between six-membered rings of L ligands from different decks with centroid-centroid distances of 3.621?(7) and 3.721?(3)?Å. In the crystal, inter-molecular O-H?O hydrogen bonds link further these three-decked chains into layers parallel to (010).

| S-EPMC3212147 | biostudies-literature

2,2,2-Tris(pyrazol-1-yl)ethanol.

Project description:The title compound TPE, C(11)H(12)N(6)O, was prepared by slow evaporation from diethyl ether. In the crystal, there is a hydrogen bond between the alcohol H atom and an N in the pyrazole ring of a neighboring mol-ecule.

| S-EPMC3089311 | biostudies-literature

4,4',4''-Tris(2-pyrid-yl)-2,2',2''-[(2,4,6-trimethyl-benzene-1,3,5-tri-yl)tris-(methyl-ene)tris-(sulfanedi-yl)]tripyrimidine.

Project description:The title compound, C(39)H(33)N(9)S(3), features a mesitylene unit substituted with three thio-ether arms. The distances from the center of mesitylene unit to the N atoms of the three pyridine rings in the arms are 10.05?(1), 9.94?(3) and 8.79?(3)?Å. The crystal structure shows weak intra-molecular C-H?N hydrogen bonds.

| S-EPMC2977171 | biostudies-literature

2,4,6-Tris-(4-fluoro-phen-yl)-2-(1-pyrid-yl)-boroxine.

Project description:Crystals of the title compound, C(23)H(17)B(3)F(3)NO(3), were obtained unintentionally by slow evaporation of a chloro-form solution of the preformed boroxine-pyridine adduct. The mol-ecule contains three fluoro-substituted benzene rings, each bonded to one of the three B atoms of a six-membered boroxine ring. A pyridyl ring is also bound to one of the B atoms through a Lewis acid-base inter-action. The binding of the pyridyl substituent causes the otherwise planar boroxine ring to twist, resulting in a maximum torsion angle within the ring of 17.6?(2)°.

| S-EPMC2915295 | biostudies-literature

Tris{2-[4-(2-pyrid-yl)pyrimidin-2-ylsulfan-yl]eth-yl}amine.

Project description:The tripodal character of the title compound, C(33)H(30)N(10)S(3), arises from the three thio-ether arms surrounding a central amine N atom. The three arms have approximately the same conformation but distinct geometries in a trans-trans-cis conformation, resulting in a short pyridine-sulfanyl N?S distance of 4.320?(7)?Å. The distances of the central N atom to the N atoms of three pyridine rings in the arms are 8.305?(7), 8.032?(7) and 5.076?(9)Å. In the crystal, mol-ecules are joined into a three-dimensional supra-molecular network via effective ?-? stacking between adjacent heterocycles [centroid-centroid distances of 3.700?(3)-4.118?(4)?Å between adjacent inter-layer pyrimidine rings and 3.676?(4)?Å between the pyridine rings].

| S-EPMC2977494 | biostudies-literature

Bis[tris-(1H-pyrazol-1-yl-?N)methane]-nickel(II) bis-{[tris-(1H-pyrazol-1-yl-?N)methane]-tris-(thio-cyanato-?N)nickelate(II)} methanol disolvate.

Project description:Attempts to prepare the mononuclear [(tpm)Ni(II)L(3)](-1) [tpm = tris-(1H-pyrazol-1-yl)methane and L = thio-cyanate] anion yielded the methanol-solvated salt, [(tpm)(2)Ni(II)][(tpm)Ni(II)(NCS)(3)](2)·2CH(3)OH or [Ni(C(10)H(10)N(6))(2)][Ni(NCS)(3)(C(10)H(10)N(6))](2)·2CH(3)OH. The asymmetric unit consists of half a centrosymmetric bis-[tris-(1H-pyrazol-1-yl)methane]-nickel(II) cation and an octa-hedral nickelate(II) anion bound to one tpm and three L ligands, and a methanol solvent mol-ecule. One of the L ligands is disordered over two positions with occupancy factors of 0.650?(3) and 0.350?(3). There are O-H?S inter-actions between the methanol and the disordered thio-cyanate anion, and a weak C-H?O hydrogen bond between the cation and the methanol O atom.

| S-EPMC3238592 | biostudies-literature

Tris(?-cyclo-penta-dien-yl)hafnium(III).

Project description:In the crystal structure of the title compound, [Hf(C(5)H(5))(3)], three cyclo-penta-dienyl ligands surround the Hf(III) atom in a trigonal-planar geometry. The mol-ecule lies on a sixfold inversion axis.

| S-EPMC3089176 | biostudies-literature

Tetra-kis[?-1,3-bis-(4,5-dihydro-1,3-oxazol-2-yl)benzene-?(2)N:N']tris-ilver(I) tris-(hexa-fluoridophosphate).

Project description:In the title compound, [Ag(3)(C(12)H(12)N(2)O(2))(4)](PF(6))(3), one Ag(I) ion, lying on a twofold rotation axis, is coordinated by four N atoms from four 1,3-bis-(4,5-dihydro-1,3-oxazol-2-yl)benzene (L) ligands in a distorted tetra-hedral geometry and the other Ag(I) ion is coordinated by two N atoms from two L ligands in a bent arrangement [N-Ag-N = 169.03?(17)°]. Two L ligands adopt a syn conformation, while the other two adopt an anti conformation. They bridge adjacent Ag(I) ions, forming a trinuclear complex. One of the PF(6) (-) anions is half-occupied, with the P atom located on a twofold rotation axis. The PF(6) (-) anions link the complex mol-ecules via Ag?F inter-actions [2.80?(2) and 2.85?(2)?Å] into a polymeric chain along [100].

| S-EPMC3435593 | biostudies-literature

[Tris(3,5-diphenyl-pyrazol-yl)hydro-borato]nickel(II) bromide.

Project description:In the title tris-(pyrazol-yl)borate (Tp(Ph2)) complex, [NiBr(C(45)H(34)BN(6))], the Ni, Br and B atoms lie on a crystallographic threefold axis and a distorted NiN(3)Br tetra-hedral geometry arises for the metal ion. In the crystal, C-H?(C=C) and C-H?? inter-actions help to establish the polar crystal packing.

| S-EPMC2969450 | biostudies-literature

trans-1,2,3-Tris(4-methoxy-benzo-yl)cyclo-propane.

Project description:In the title compound, C(27)H(24)O(6), the packing of the mol-ecules is mainly governed by C-H?O inter-actions.

| S-EPMC2968624 | biostudies-literature